Yang and his colleagues reported that combinational gene therapy using IL-12, pro-IL-18, and IL-1β converting enzyme (ICE) cDNA expression vectors simultaneously delivered via a gene gun could significantly augment anti-tumor effects by generating increased levels of bioactive IL-18 and consequently IFN-γ. This evidence concerns the gene IL18 and neoplasm.